Results
1 -
10 of
14A Population Pharmacokinetic/Pharmacodynamic Analysis of Regadenoson, an Adenosine A2A-Receptor Agonist, in Healthy Male Volunteers, Clinical Pharmacokinetics Peptide Receptor Antagonists and Monoclonal Antibodies Raised Against Peptides: Tools to Study Physiological Regulation of Pancreatic Function, Biochemical Pharmacology as an Approach to Gastrointestinal Disorders Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dog, European Journal of Drug Metabolism and Pharmacokinetics Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the rat, European Journal of Drug Metabolism and Pharmacokinetics Pharmacodynamic and Clinical Endpoints for Functional Colonic Disorders: Statistical Considerations, Digestive Diseases and Sciences Effect of Three Nonpeptide Cholecystokinin Antagonists on Human Isolated Gallbladder, Digestive Diseases and Sciences Treatment of functional dyspepsia, Current Treatment Options in Gastroenterology Should we stop prescribing metoclopramide as a prokinetic drug in critically ill patients?, Critical Care